IL-10-producing regulatory cells impact on celiac disease evolution
Copyright © 2023. Published by Elsevier Inc.
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 260(2024) vom: 11. März, Seite 109923 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , , , , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2024
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Journal Article Research Support, Non-U.S. Gov't Gliadin-specific T cells Interleukin 10 Potential celiac disease T regulatory type 1 Tolerogenic dendritic cells Villous atrophy Gliadin 9007-90-3 mehr... |
Zusammenfassung: | Copyright © 2023. Published by Elsevier Inc. Celiac Disease (CD) is a T-cell mediated disorder caused by immune response to gluten, although the mechanisms underlying CD progression are still elusive. We analyzed immune cell composition, plasma cytokines, and gliadin-specific T-cell responses in patients with positive serology and normal intestinal mucosa (potential-CD) or villous atrophy (acute-CD), and after gluten-free diet (GFD). We found: an inflammatory signature and the presence of circulating gliadin-specific IFN-γ+ T cells in CD patients regardless of mucosal damage; an increased frequency of IL-10-secreting dendritic cells (DC-10) in the gut and of circulating gliadin-specific IL-10-secreting T cells in potential-CD; IL-10 inhibition increased IFN-γ secretion by gliadin-specific intestinal T cells from acute- and potential-CD. On GFD, inflammatory cytokines normalized, while IL-10-producing T cells accumulated in the gut. We show that IL-10-producing cells are fundamental in controlling pathological T-cell responses to gluten: DC-10 protect the intestinal mucosa from damage and represent a marker of potential-CD |
---|---|
Beschreibung: | Date Completed 19.02.2024 Date Revised 10.04.2024 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1521-7035 |
DOI: | 10.1016/j.clim.2024.109923 |